Amgen Inc
Change company Symbol lookup
Select an option...
AMGN Amgen Inc
WMT WALMART STORES INC
TOYOF Toyota Motor Corp
IIVI II-VI Inc
ALL Allstate Corp
MLLCF Molecular Partners AG
PLD Prologis Inc
CHKP Check Point Software Technologies Ltd
TSLA Tesla Inc
AAPL Apple Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Closing Price
$253.50
Day's Change
1.47 (0.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
255.23
Day's Low
250.56
Volume
(Light)
Volume:
1,866,583

10-day average volume:
2,431,032
1,866,583
  • Prev Close
    252.03
  • Today's Open
    252.26
  • Day's Range
    250.56-255.23
  • Avg Vol (10-day)
    2.4M
  • Last (time)
    4:00p ET 01/22/21
  • Last (size)
    1
  • 52-Wk Range
    177.05 - 264.97
    LowHigh
  • (03/23/20 - 07/06/20)
    4.33%
  • 38.3%
  • Market Cap
    147.6B
  • Shares Outstanding
    582.2M
  • 12.40
  • 20.44x
  • $7.04/2.78%
  • Ex-dividend Date
    02/11/21
  • Dividend Pay Date
    03/08/21
  • 0.8
  • 74.52
  • (% of float 12/31/20)
    1.20

Latest News

January 21, 2021
7:55 am ET
Globe Newswire
January 20, 2021
4:44 pm ET
BusinessWire
January 18, 2021
8:50 am ET
Globe Newswire
January 15, 2021
4:30 am ET
BusinessWire
January 13, 2021
5:00 am ET
PR Newswire
January 12, 2021
9:00 am ET
PR Newswire
January 11, 2021
4:45 pm ET
PR Newswire
5:30 am ET
BusinessWire
January 07, 2021
11:05 am ET
MarketWatch
5:00 am ET
BusinessWire
January 06, 2021
4:00 pm ET
PR Newswire
4:00 am ET
BusinessWire
January 05, 2021
8:30 am ET
PR Newswire
January 02, 2021
8:17 am ET
MarketWatch
December 23, 2020
8:04 am ET
Globe Newswire
7:57 am ET
BusinessWire
December 22, 2020
4:00 pm ET
PR Newswire
2:00 am ET
PR Newswire
December 21, 2020
3:59 pm ET
BusinessWire
7:49 am ET
Globe Newswire
4:57 am ET
Globe Newswire
December 18, 2020
6:44 am ET
Globe Newswire
6:34 am ET
Globe Newswire
6:14 am ET
Globe Newswire
4:00 am ET
Globe Newswire
December 17, 2020
4:10 pm ET
PR Newswire
4:00 pm ET
PR Newswire
December 16, 2020
5:00 pm ET
PR Newswire
4:30 pm ET
PR Newswire
4:00 pm ET
PR Newswire
December 15, 2020
6:31 am ET
Globe Newswire
December 10, 2020
2:49 pm ET
BusinessWire
4:53 am ET
Globe Newswire
4:48 am ET
Globe Newswire
4:43 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.